XML 41 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Assets:    
Cash $ 225,723 $ 108,619
Securities available-for-sale, at estimated fair value 64,216 67,079
Securities, at estimated fair value 198,457 211,809
Commercial mortgage loans, held for investment 142,833 142,921
Subordinate loans, held for investment 286,569 246,246
Repurchase agreements, held for investment   6,598
Interest receivable 4,475 4,277
Deferred financing costs, net 1,239 678
Other assets   203
Total Assets 923,512 788,430
Liabilities:    
Borrowings under repurchase agreements 211,944 225,158
Derivative instruments, net 83 155
Accounts payable and accrued expenses 1,524 1,265
Payable to related party 2,160 2,037
Dividends payable 16,616 12,891
Total Liabilities 232,327 241,506
Commitments and Contingencies (see Note 13)      
Stockholders' Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized and 3,450,000 shares issued and outstanding in 2013 and 2012 35 35
Common stock, $0.01 par value, 450,000,000 shares authorized, 36,869,106 and 28,044,106 shares issued and outstanding in 2013 and 2012, respectively 369 280
Additional paid-in-capital 695,266 546,065
Retained earnings (accumulated deficit) (4,297) 574
Accumulated other comprehensive loss (188) (30)
Total Stockholders' Equity 691,185 546,924
Total Liabilities and Stockholders' Equity $ 923,512 $ 788,430